Search research articles
Contact Us
Filters
Showing results (41-50 of 105) with videos related to
Page
of 11
Sort By:
European Journal of Pharmacology
|
March 12, 1982
High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline
R Raisman, M Sette, C Pimoule, et al.
Science (New York, N.Y.)
|
July 11, 1980
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients
M S Briley, S Z Langer, R Raisman, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1987
Beta-adrenergic agonists reduce spontaneous motor activity through either beta 1 or beta 2 receptors
H Frances, N Renwart, S Danti, et al.
Synapse (New York, N.Y.)
|
September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex
L Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Neuroscience
|
January 1, 1990
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study
F Thibaut, E C Hirsch, R Raisman, et al.
Brain Research. Molecular Brain Research
|
July 1, 1997
Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat
P Salin, G Dziewczapolski, O S Gershanik, et al.
Psychopharmacology
|
January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers
R Raisman, D Sechter, M S Briley, et al.
Neuropharmacology
|
December 1, 1980
[3H]-Imipramine binding in human platelets: a new biochemical parameter in depression
M S Briley, R Raisman, D Sechter, et al.
Neuropharmacology
|
March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain
C Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Science (New York, N.Y.)
|
December 5, 1980
High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine
S Z Langer, C Moret, R Raisman, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 105) with videos related to
Sort By:
Page
of 11
European Journal of Pharmacology
|
March 12, 1982
High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline
R Raisman, M Sette, C Pimoule, et al.
Science (New York, N.Y.)
|
July 11, 1980
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients
M S Briley, S Z Langer, R Raisman, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1987
Beta-adrenergic agonists reduce spontaneous motor activity through either beta 1 or beta 2 receptors
H Frances, N Renwart, S Danti, et al.
Synapse (New York, N.Y.)
|
September 1, 1995
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex
L Naudon, I Leroux-Nicollet, R Raisman-Vozari, et al.
Neuroscience
|
January 1, 1990
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study
F Thibaut, E C Hirsch, R Raisman, et al.
Brain Research. Molecular Brain Research
|
July 1, 1997
Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat
P Salin, G Dziewczapolski, O S Gershanik, et al.
Psychopharmacology
|
January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers
R Raisman, D Sechter, M S Briley, et al.
Neuropharmacology
|
December 1, 1980
[3H]-Imipramine binding in human platelets: a new biochemical parameter in depression
M S Briley, R Raisman, D Sechter, et al.
Neuropharmacology
|
March 23, 2000
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain
C Vilpoux, I Leroux-Nicollet, L Naudon, et al.
Science (New York, N.Y.)
|
December 5, 1980
High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine
S Z Langer, C Moret, R Raisman, et al.
Page
of 11